MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Pupil evaluation as the test for the clinical manifestations of Parkinson’s disease

T. Araga, M. Shiraishi, K. Shinohara, Y. Hasegawa (Kawasaki, Japan)

Meeting: 2018 International Congress

Abstract Number: 1688

Keywords: Autonomic dysfunction, Eye movement

Session Information

Date: Monday, October 8, 2018

Session Title: Parkinson's Disease: Pathophysiology

Session Time: 1:15pm-2:45pm

Location: Hall 3FG

Objective: We clarify the correlation between abnormality in 123I-metaiodobenzylguanidine (MIBG) scintigraphy and task-evoked pupillary response in Parkinson’s disease (PD) patients.

Background: MIBG scintigraphy is one of the supportive feature of Lewy body disease which can be demonstrate myocardial postganglionic sympathetic dysfunction. Recently, video eye trackers with a high-resolution camera has been utilized to measure the task-evoked pupillary response, however little work has been done to evaluate autonomic failure in PD.

Methods: 19 PD patients (mean age: 74.3 ± 8.2 years, Hoehn-Yahr stage: 2.9 ± 0.7, disease durations: 7.6 ± 5.3 years) were examined. Both MIBG scintigraphy and task-evoked pupillary response were evaluated in all patients. Pupil response was measured using the eye-tracking software at a sampling of 60 Hz. Pupillary response was measured using two conditions, (1) 18 second maximum hand grip tasks (HG) and (2) 10 second light stimulus from 80 lux to 400 lux (LS). Normal values were obtained from 10 healthy volunteers.

Results: Pupillary response in HG task in PD patients was significantly lower than in controls (24.4±4.8% vs 47.7±14.7%, p=0.001). Pupillary response in LS was 24.4±4.8% in PD group, and it was significantly correlated with disease durations (r=0.521, P=0.027), levodopa equivalent dose (r=0.498, P=0.036), and UPDRS partⅣ(r=0.0608, P=0.027). There was no correlation between pupillary response in HG and the heart to mediastinum (H/M) ratio in delayed image of 123I-MIBG cardiac scintigraphy. 

Conclusions: Pupillary response in PD patients could be utilized as an indicator of progression marker in PD. Further studies are warranted to explore the relationship between pupillary response and other autonomic failure in PD.

To cite this abstract in AMA style:

T. Araga, M. Shiraishi, K. Shinohara, Y. Hasegawa. Pupil evaluation as the test for the clinical manifestations of Parkinson’s disease [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/pupil-evaluation-as-the-test-for-the-clinical-manifestations-of-parkinsons-disease/. Accessed May 18, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/pupil-evaluation-as-the-test-for-the-clinical-manifestations-of-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • Welcome to the MDS Abstracts Site
      • Effect of marijuana on Essential Tremor: A case report
      • Advanced Search
      • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
      • Covid vaccine induced parkinsonism and cognitive dysfunction
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley